Drug Shortage Report for BUSCOPAN

Last updated on 2024-03-26 History
Report ID 206788
Drug Identification Number 00363839
Brand name BUSCOPAN
Common or Proper name Buscopan
Company Name SANOFI CONSUMER HEALTH INC
Market Status MARKETED
Active Ingredient(s) HYOSCINE BUTYLBROMIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 12
ATC code A03BB
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-10-11
Actual start date 2023-10-11
Estimated end date 2024-03-22
Actual end date 2024-03-25
Shortage status Resolved
Updated date 2024-03-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2905 PLACE LOUIS-R RENAUD
LAVAL, QUEBEC
CANADA H7V 0A3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2024-03-26 English Compare
v14 2024-03-25 French Compare
v13 2024-03-25 English Compare
v12 2024-03-06 French Compare
v11 2024-03-06 English Compare
v10 2024-02-06 English Compare
v9 2024-02-06 English Compare
v8 2024-01-24 English Compare
v7 2024-01-10 French Compare
v6 2024-01-10 English Compare
v5 2024-01-08 French Compare
v4 2024-01-08 English Compare
v3 2023-10-12 English Compare
v2 2023-10-11 French Compare
v1 2023-10-11 English Compare

Showing 1 to 15 of 15